Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2019-2024

The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides the reader with the following key benefits:

 

• In-depth understanding of discovery stage deal trends since 2019
• Access to headline, upfront, milestone and royalty data
• Comprehensive access to over 2,900 discovery stage deals together with contract documents if available
• Detailed access to actual discovery stage deals entered into by the leading 25 big pharma and big biotech companies along with other biopharma companies
• Analysis of the structure of discovery stage agreements with numerous real life case studies
• Identify leading discovery stage deals by value since 2019
• Identify the most active discovery stage dealmakers since 2019
• Full listing of discovery stage deals by company A-Z, phase of development, deal type, therapy and technology focus
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

               

Chapter 1 – Introduction

 

Chapter 2 – Why do companies partner at discovery stage?

2.1. Introduction

2.2. The role of discovery stage partnering

2.2.1. In-licensing at discovery stage

2.2.2. Out-licensing at discovery stage

2.3. Difference between discovery, preclinical and clinical stage deals

2.4. Reasons for entering into discovery stage partnering deals

2.4.1. Licensors reasons for entering discovery stage deals

2.4.2. Licensees reasons for entering discovery stage deals

2.5. The future of discovery stage partnering deals

 

Chapter 3 – Discovery stage deal strategies and structure

3.1. Introduction

3.2. At what stage do companies partner?

3.2.1. Partnering early in pharmaceutical/biotech

3.2.1.1. Discovery and preclinical stage partnering case studies

3.2.1.1.a. Case study 1

3.2.1.1.b. Case study 2

3.2.1.1.c. Case study 3

3.2.1.1.d. Case study 4

3.2.2. Partnering later in pharmaceutical/biotech

3.2.2.1. Clinical stage partnering case studies

3.2.2.1.a. Case study 5

3.2.2.1.b. Case study 6

3.2.2.1.c. Case study 7

3.2.2.1.d. Case study 8

3.3. Early and later stage partnering – a risk/cost comparison

3.4. What do companies spend on discovery, preclinical and clinical stage partnering?

3.5. Pure versus multi-component partnering deals

3.6. Pure licensing agreement structure

3.6.1. Example pure licensing agreements

3.6.1.a. Case study 9

3.6.1.b. Case study 10

3.7. Multicomponent discovery stage partnering agreements

3.7.1.a. Example multicomponent early stage clauses

3.7.1.a. Case study 11

3.7.1.b. Case study 12

 

Chapter 4 – Discovery stage partnering payment strategies

4.1. Introduction

4.2. Discovery stage payment strategies

4.3. Payment options

4.3.1. Headline values

4.3.2. Upfront payments

4.3.2.1. Conditionality of upfront payments

4.3.3. Loans

4.3.4. Convertible loans

4.3.5. Equity

4.3.6. R&D funding

4.3.7. Licensing fees

4.3.8. Milestone payments

4.3.9. Royalty payments

4.3.9.1. Issues affecting royalty rates

4.3.9.2. Royalties on combination products

4.3.9.2.a. Case study 13

4.3.9.3. Guaranteed minimum/maximum annual payments

4.3.9.4. Royalty stacking

4.3.9.5. Royalties and supply/purchase contracts

4.3.10. Quids

4.3.11. Option payments

 

Chapter 5 – Trends in discovery stage deal making

5.1. Introduction

5.2. Discovery stage partnering over the years

5.2.1. Attributes of discovery deals

5.3. Discovery stage partnering by deal type

5.4. Discovery stage partnering by disease type

5.5. Partnering by discovery stage technology type

5.6. Discovery stage partnering by most active company, 2019 to 2024

 

Chapter 6 – Payment terms for discovery stage partnering

6.1. Introduction

6.2. Guidelines for discovery stage payment terms

6.2.1. Upfront payments

6.2.2. Milestone payments

6.2.3. Royalty payments

6.3. Discovery stage payment terms – deal data analysis

6.3.1. Public data

6.3.2. Survey data

6.4. Payment terms analysis

6.4.1. Discovery stage headline values

6.4.2. Discovery stage deal upfront payments

6.4.3. Discovery stage deal milestone payments

6.4.4. Discovery stage royalty rates

 

Chapter 7 – Leading discovery stage deals

7.1. Introduction

7.2. Top discovery stage deals by value

 

Chapter 8 – Top 25 most active discovery stage dealmakers

8.1. Introduction

8.2. Top 25 most active discovery stage dealmakers

 

Chapter 9 – Discovery stage partnering contracts directory

9.1. Introduction

9.2. Discovery stage deals with contracts 2019 to 2024

 

Chapter 10 – Discovery stage deal making by development stage

 

10.1. Introduction

10.2. Deals by discovery stage

 

 

Appendices

                                   

Appendix 1 – Discovery stage dealmaking by companies A-Z

Appendix 2 – Discovery stage dealmaking by industry sector

Appendix 3 – Discovery stage dealmaking by stage of development

Appendix 4 – Discovery stage dealmaking by therapy area

Appendix 5 – Discovery stage dealmaking by technology type

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Definition of discovery, preclinical and clinical phases in dealmaking

Figure 3: Components of the pure licensing deal structure

Figure 4: Payment options for discovery stage partnering deals

Figure 5: Issues affecting royalty rates   

Figure 6: Discovery stage partnering frequency 2019 - 2024       

Figure 7: Discovery stage partnering by deal type since 2019     

Figure 8: Discovery stage partnering by disease type since 2019

Figure 9: Discovery stage partnering by technology type since 2019        

Figure 10: Top 25 most active discovery stage dealmakers, 2019 to 2024

Figure 11: Review of median upfront payments for discovery stage deals

Figure 12: Review of median milestone payments for discovery stage deals        

Figure 13: Review of median royalty payments for discovery stage deals 

Figure 14: Discovery stage deals with a headline value  

Figure 15: Discovery stage deals with an upfront value   

Figure 16: Discovery stage deals with a milestone value 

Figure 17: Discovery stage deals with a royalty rate value           

Figure 18: Top discovery stage deals by deal value since 2019   

Figure 19: Most active discovery stage dealmakers 2019 to 2024

Pricing options

• $3995: Single-user
• $5995: Multi-user (2-5 users)
• $7995: Corporate (unencrypted PDF)

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Biopharma Research Ltd., based in York, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1ST Biotherapeutics, 2seventy bio, 3B Pharmaceuticals, 3SBio, 3T Biosciences, 3Z, 4basebio Discovery, 4B Technologies, 4C Biomed, 4D Molecular Therapeutics, 4D Pharma, 4E Therapeutics, 4P-Pharma, 7 Hills Pharma, 10X Genomics, 22nd Century, 23andMe, 48Hour Discovery, 1910 Genetics, A*STAR Agency for Science, Technology and Research, A*STAR Bioprocessing Technology Institute, A*STAR Singapore Immunology Network, A*STAR’ Institute of Molecular and Cell Biology, A-Alpha Bio, A2A Pharmaceuticals, Aachen University, Aarhus University, Aarvik Therapeutics, AavantiBio, AAVnerGene, Abbisko Therapeutics, Abbvie, Abcam, AbCellera Biologics, AbCheck, Abcuro, Abera Bioscience, Abilita Bio, Abintus Bio, ABL Bio, Ablexis, Ab Magnitude Ventures, Abound Bio, Aboundbio, AbSci, Absolute Antibody, Ab Studio, AbTis, ABVC BioPharma, Abveris, ACADIA Pharmaceuticals, AC Bioscience, Accelerate Technologies, Accelerator for Technological Research in Genomic Therapies, Acceleron Pharma, Accent Therapeutics, Accurus Biosciences, Accutar Biotechnology, Acerand Therapeutics, Acerta Pharma, Achilles Therapeutics, AchilleS Vaccines, AC Immune, Aclaris Therapeutics, Acrobat Genomics, Actinium Pharmaceuticals, ACT Therapeutics, Actuate Therapeutics, Acuitas Therapeutics, Acurx Pharmaceuticals, Adagene, AdAlta, Adapsyn Bioscience, Adaptate Biotherapeutics, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, AdaptVac, Adcendo, Adcentrx Therapeutics, ADC Therapeutics, Addex Therapeutics, Adicet Bio, Adimab, Adnab, Adolore Biotherapeutics, AdoRx Therapeutics, Adrestia, ADT Pharmaceuticals, Advaite, Advaxis, AdventHealth, Aegis Life, Aelian Biotechnology, Aerogen, Aethlon Medical, Aethon Therapeutics, Affilogic, Affimed Therapeutics, Affini-T Therapeutics, Affinia Therapeutics, Affinity Biosciences, AffyXell Therapeutics, Afrigen Biologics, AgBiome, AGC Biologics, Age Labs, Agenus Bio, AgeX Therapeutics, Agilent Technologies, AgomAb Therapeutics, AgonOx, AHN Autoimmunity Institute, Aichi Medical University, AiCuris, Aignostics, AIkido Pharma, AimedBio, AIM ImmunoTech, Aimmune Therapeutics, Ainnocence, AI Proteins, Aitia, Ajinomoto, Akadeum Life Sciences, Akers Biosciences, Akoya Biosciences, Akrevia Therapeutics, Akshaya Bio, Aktis Oncology, Alamar Biosciences, Alchemab, Aldevron, Alector, Alexion Pharmaceuticals, Alex’s Lemonade Stand Foundation, Aligning Science Against Parkinson’s, Aligos Therapeutics, AlivaMab Discovery Services, ALK-Abello, Allegheny General Hospital, Allele Biotechnology and Pharmaceuticals, Allen Institute for Brain Science, Allen Institute for Immunology, Allergan, Alligator Bioscience, Allogene Overland Biopharm, Allogene Therapeutics, Alloplex Biotherapeutics, Alloy Therapeutics, Almirall, Alnylam Pharmaceuticals, Alpha Biopharma, Alpha Cancer Technologies, Alphageneron Pharmaceuticals, Alpha Tau Medical, Alpine Immune Sciences, Altamira Therapeutics, Alterity Therapeutics, Alveo Technologies, ALX Oncology, Alyatec, Alytas Therapeutics, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Amagma Therapeutics, Amarna Therapeutics, Amathus Therapeutics, Ambiopharm, Ambrx, American Association for Cancer Research, American BriVision, American Society of Hematology, American Type Culture Collection (ATCC), Amfora, Amgen, Amicogen, Amicus Therapeutics, AmMax Bio, Amphilix, Amphista Therapeutics, AMRA Medical, Amunix, Amylyx Pharmaceuticals, Amyris, AN2 Therapeutics, Anagenex, AnaMar, ANANDA Scientific, Anavo Therapeutics, Anchiano Therapeutics, Angiogenesis Foundation, Angios, Anima Biotech, Anixa Biosciences, Anji Pharma, Ankarys Therapeutics, Ankyra Therapeutics, Annogen, Antengene, Antibe Therapeutics, Antikor Biopharma, Antion Biosciences, Antios Therapeutics, Antiverse, Apellis Pharmaceuticals, Apollo Therapeutics, Appia Bio, Applied BioMath, Applied DNA Sciences, Applied Genetic Technologies, Applied StemCell, Aprecia Pharmaceuticals, APRINOIA Therapeutics, Aptahem, Aptamer Therapeutics, Aptinyx, Aptorum Group, Aqemia, Aqilion, Aquinnah Pharmaceuticals, Aquitaine Science Transfert (SATT Aquitaine), Aragen Life Sciences, Araris Biotech, ARase Therapeutics, Aravive Biologics, Arbele, Arbor Biotechnologies, Arbutus, ARCA Biopharma, Arcellx, ARC Therapeutics, Arctic Vision, Arctoris, Arcturus Therapeutics, Arcus Biosciences, Ardeagen, Ardelyx, Ardigen, Arecor, Arena Pharmaceuticals, Ares Genetics, argenx, Argobio, Ariana Pharma, Ariceum Therapeutics, Aridis Pharmaceuticals, Ariel Precision Medicine, Arima Genomics, Arizona State University, Arnay Sciences, Aro Biotherapeutics, Arrakis Therapeutics, Arrowhead Pharmaceuticals, Arsenal Biosciences, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Artizan Biosciences, Arzeda, Ascidian Therapeutics, ASC Therapeutics, Asieris Pharmaceuticals, ASKA Pharmaceuticals, Asklepios Biopharmaceutical, Aspect Biosystems, Assembly Biosciences, Associazione Poic e Dintorni APS, Astellas Pharma, Astellas Pharma US, Astex Pharmaceuticals, AstraZeneca, Astrogen, AstronauTx, Asylia Therapeutics, ATAI Life Sciences, Atalanta Therapeutics, Atara Biotherapeutics, Atavistik Bio, Athebio, Athenex, Athos Therapeutics, Atlas Venture, Atomwise, ATP, Atrapos Therapeutics, Atreca, Atropos Therapeutics, ATUM, aTyr Pharma, AUM Biosciences, Auransa, Aurigene Discovery Technologies, Australian Research Council, Autifony Therapeutics, Autigen, Autolus, Autotelic BIO, Avacta, Avactis Biosciences, Avalon GloboCare, AvantGen, Avatamed, Avectas, Aviceda Therapeutics, Avicenna Biosciences, Avidity Biosciences, Avista Therapeutics, Avrobio, Axcelead Drug Discovery Partners, Axcella, Axial Biotherapeutics, Axis Therapeutics, Axovant Gene Therapies, Axxam, AyoxxA Biosystems, Azitra, Azos Bio, B-MoGen Biotechnologies, BAKX Therapeutics, Barer Institute, Barrow Neurological Institute, Baruch S Blumberg Institute, Base4 Biotechnology, BASF, Basilea Pharmaceutica, Batavia Biosciences, Battelle, Baxalta, Baxter International, Bayer, Baylor College, Baylor College of Medicine, BCD Bioscience, BC Platforms, Beacon Biosignals, Beacon Discovery, Beactica, Beam Therapeutics, Beartooth Therapeutics, BehaVR, Beiersdorf, BeiGene, Beijing Genomics Institute (BGI), Beijing Tide Pharmaceutical, Beijing University of Chinese Medicine, Belharra Therapeutics, Bellicum Pharmaceuticals, Ben-Gurion University, Benaroya Research Institute, BenevolentAI, Berg, Berkeley Lights, Beroni Group, Berry Genomics, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, BGN Technologies, Bharat Biotech, Bicycle Therapeutics, Bielefeld University, BigHat Biosciences, Bill and Melinda Gates Foundation, Binghamton University, Bintai Kinden, Bio-Cancer Treatment International, Bio-Techne, BioAge Labs, BioArctic AB, biOasis Technologies, BIOASTER, BioCardia, BioComo, BioCopy, BioCurate, BiocurePharm, Biocytogen, Biodextris, BioDuro, Biogen, Biognosys, Biohaven Pharmaceuticals, BioInvent, BioKey, BioLite Japan, Biolojic Design, BioMap, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, Biomedical Primate Research Centre, BioMed X Innovation Center, bioMerieux, Biomica, Biomillenia, BioMotiv, Biomunex Pharmaceuticals, BiomX, BiondVax, BiOneCure Therapeutics, Bioneer, Bionetix, Bioniz Therapeutics, BioNova Pharmaceuticals, BioNTech, BionX Medical Technologies, Bio Palette, Bioqube Ventures, Biorchestra, Biortus Biosciences, Biosceptre International, Biosion, Biositu Pharmaceutical Technology, BioSkryb, BioStrand, BioSymetrics, Biotem, BioTheryX, Biotheus, Biotools, Biotx.ai, BioVaxys, BioVersys, BIRAD Research and Development Company, Bird Foundation, Bit Bio, bitBiome, Bitterroot Bio, BiVictriX Therapeutics, Blackford, Blacksmith Medicines, BliNK Biomedical, Bloom Science, Blu Biotech, Bluebird Bio, Bluebridge Technologies, Blue Diamond Growers, Blueprint Medicines, BlueRock Therapeutics, Blue Water Vaccines, Boca Biolistics, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bohai Biomedical, Bolt Biotherapeutics, Boostimmune, Boragen, Boston Biomedical, BostonGene, Boulos and Cooper Pharmaceuticals, BRAIN Biotech, BrainXell, BravoVax, Breath Diagnostics, BriaCell Therapeutics, BrickBio, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, BrightPath Biotherapeutics, Bright Peak Therapeutics, Brightseed, Brii Biosciences, Bristol-Myers Squibb, Broad Institute, Broadwing Bio, Brooklyn ImmunoTherapeutics, Brown University, BullFrog AI, Bunker Pflanzenextrakte, Byondis, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Calcimedica, Calico, Calidi Biotherapeutics, California Institute for Biomedical Research, California Institute for Regenerative Medicine, California Institute of Technology, Calixar, Calyxt, Cambridge Quantum Computing, Camino Pharma, CAMP4 Therapeutics, Can-Fite BioPharma, CanAm Bioresearch, CANbridge Pharmaceuticals, Cancer Genetics, Cancer Research Horizons, Cancer Research UK, Canopy Biosciences, Cantabio Pharmaceuticals, Cantargia, Capricor Therapeutics, Capsida Biotherapeutics, Capsigen, Captor Therapeutics, Caravan Biologix, Caraway Therapeutics, CARB-X, Carbiotix, Cardiff Oncology, Cardiff University, CARE, Carepay, Caribou Biosciences, Carina Biotech, Caris Life Sciences, Carisma Therapeutics, Carmine Therapeutics, Carna BioSciences, Carterra, Cartexell, Cartherics, Casdin Capital, Case Western Reserve University, Casma Therapeutics, Castle Creek Biosciences, CasZyme, Catalent, Catamaran Bio, Catholic University Leuven, CDR-Life, Ceapro, Cedars-Sinai Medical Center, Cedilla Therapeutics, Celdara Medical, CelerisTx, Celgene, Cell&Soft, Cellaria Biosciences, Cellarity, Cellectis, Cellectricon, Cellerant Therapeutics, Cellerys, Cellesce, Cellevolve Bio, Cellinfinity Bio, CELLINK, Cellkey, Cell Mogrify, CellOrigin Biotech, Cellscript, Cell Signaling Technology, Celltrion, Cellular Biomedicine, Celmatix, Celonic, Celsius Therapeutics, Celularity, Centene, Center for Biomarker Research in Medicine, Center for Genomic Regulation, Centessa Pharmaceuticals, Centogene, Centre for Commercialization of Regenerative Medicine (CCRM), Centre Leon Berard, Century Therapeutics, Cepheid, Cerebras Systems, Cerecin, Cerecor, Cerevance, Cerevel Therapeutics, CERo Therapeutics, Certara, Cerveau Technologies, Cevec Pharmaceuticals, CGA 369, Chamishi Therapeutics, Champions Oncology, Charite Universitatsmedizin Berlin, Charles River Laboratories, CHARM Therapeutics, Checkpoint Therapeutics, Chelexa Biosciences, Chemify, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital of Philadelphia, Children's Medical Research Institute, Children's Mercy Hospital, Children's National Hospital, Chimeric Therapeutics, China-Singapore Guangzhou Knowledge City, China National Biotech Group (CNBG), Chinese Academy of Sciences, Chinook Therapeutics, Chiome Bioscience, Cholesgen, Chonnam National University, CHO Plus, Chroma Medicine, Chugai Pharmaceutical, CIC nanoGUNE, CiMaas, Cimeio Therapeutics, Circular Genomics, Citranvi Biosciences, City of Hope, Civetta Therapeutics, CK Life Sciences, Clarity Pharmaceuticals, Clarus Therapeutics, Clear Creek Bio, Clearmind Medicine, Cleveland Clinic, Cleveland University Hospitals, Clover Biopharmaceuticals, Clover Therapeutics, Clovis Oncology, CM Life Sciences, CMT Research Foundation, CN Bio, CNS Pharmaceuticals, Coalition for Epidemic Preparedness Innovations, Coave Therapeutics, Cocrystal Pharma, CODA Biotherapeutics, Codagenix, Code Biotherapeutics, Codex DNA, Codexis, Codiak BioSciences, Coeptis Therapeutics, Cogia Biotech, CogState, CoImmune, Collaborations Pharmaceuticals, Collplant, Colombia Ministry of Health and Social Protection, Colorado Center for Personalized Medicine, Colorado State University, Columbia University, Combined Therapeutics, Combotope Therapeutics, Comera Life Sciences, Complete Phytochemical Solutions, Complix, Concept Life Sciences, ConcertAI, Concr, Confo Therapeutics, Conkwest, ConserV Bioscience, ConsortiaTX, Contera Pharma, Context Therapeutics, Contour Therapeutics, Convelo Therapeutics, Cornell University, Corporation for Biological Research, Corteva Agriscience, Corvidia Therapeutics, Covant Therapeutics, Crescendo Biologics, CRISPR Therapeutics, Cristal Therapeutics, Crohn's and Colitis Foundation of America, Crown Bioscience, CSIRO, CSL, CSL Behring, CStone Pharmaceuticals, CtM Biotech, Cue Biopharma, Cullgen, Cullinan Oncology, Cumberland Emerging Technologies, Curadev Pharma, Curadigm, Curasan, Curasight, Cure Duchenne, Cure Genetics, Curetis, CureVac, Curia, Curiox Biosystems, Curreio, CVC, Cybin, Cyclenium Pharma, Cyclerion Therapeutics, Cyclica, Cyclo Therapeutics, Cynata Therapeutics, Cyrus Biotechnology, Cystic Fibrosis Foundation, Cytocom, CytoImmune Therapeutics, CytoLynx Therapeutics, CytoMed Therapeutics, CytomX Therapeutics, Cytoo, CytoReason, CytoSen Therapeutics, Cytosurge, Cytovance Biologics, Cytovant Sciences, CYTOVIA Therapeutics, D2M, DAAN Bio Therapeutics, Daewoong Pharmaceutical, Daiichi Sankyo, Dalhousie University, Dalriada Drug Discovery, Dana-Farber Cancer Institute, Dana Farber Partners Cancer Care, DanausGT Biotechnology, Dartmouth College, DarwinHealth, Dassault Systems, Day One Biopharmaceuticals, DayTwo, Debiopharm, Decibel Therapeutics, deCODE Genetics, DeepCDR Biologics, Deep Genomics, Deep Longevity, Deerfield Management, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Delix Therapeutics, Delta 4, Dementia Discovery Fund, Dementia Research Institute, Denali Therapeutics, Denovium, Department of Defence, Department of Defense, Dermelix Biotherapeutics, Dewpoint Therapeutics, Diamond Light Source, Dicerna Pharmaceuticals, DiNAQOR, DIOSynVax, Disc Medicine, Discngine, Distributed Bio, DNA Script, DNX Biopharmaceuticals, doc.ai, Domainex, Door Pharmaceuticals, Dorian Therapeutics, DotBio, Dragonfly Therapeutics, Dren Bio, Drexel University, Drugs for Neglected Diseases Initiative, DualityBio, Dualogics, Dualsystems Biotech, Duke-NUS Graduate Medical School Singapore, Duke University, Dunad Therapeutics, DuPont Pharmaceuticals, Dyadic International, DyNAbind, Dynavax Technologies, Dyno Therapeutics, DYO Biotechnologies, E.T. Horn, Eberhard Karls University Tubingen, Edesa Biotech, EdiGene, EDIRNA, Edison Oncology, Editas Medicine, EditForce, eFFECTOR Therapeutics, Egle Therapeutics, Eikonizo Therapeutics, Eikonoklastes Therapeutics, Eisai, Elaaj Bio, Elasmogen, ElevateBio, Elevation Oncology, Eleven Biotherapeutics, Elevian, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Elix, Elixirgen, Elpiscience, Elsie Biotechnologies, Elysium Health, Embark Biotech, EMD Serono, Emendo Biotherapeutics, Emergence Therapeutics, Emergent BioSolutions, Emergex Vaccines, Emory University, Empirico, Enamine, Enara Bio, Endevica Bio, Endogena Therapeutics, Engitix, Enigma Biomedical, Enleofen Bio, Ensoma, Enterome Bioscience, Enterprise Ireland, Enveric Biosciences, Envisagenics, Enzolytics, EpiAxis Therapeutics, Epidemiologic Solutions, EpimAb Biotherapeutics, EpiPharma, Epivax, EpiVax Therapeutics, Epsilogen, EQRx, Equillium, Eracal Therapeutics, Erasmus University Medical Center, ERS Genomics, Ervaxx, ErVimmune, Erytech Pharma, Escient Pharmaceuticals, Escugen, EsoCap, Esperovax, Essex Bio-Technology, Eterna Therapeutics, eTheRNA immunotherapies, Ethos Discovery, Ethris, ETH Zurich, Eucure Biopharma, Eureka Eurostars, Eureka Therapeutics, Eurocine Vaccines, Eurofins Discovery, European Investment Bank, European Molecular Biology Laboratory, European Union, European Union Regional Development Fund, Eutilex, Evaxion Biotech, EV Biologics, Evercyte, Everest Medicines, Evergreen Theragnostics, EVerZom, Evive Biotechnology, EvolveImmune Therapeutics, Evommune, Evopoint Biosciences, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, EVQLV, Evrys Bio, Exacis Biotherapeutics, Exagen Diagnostics, ExcellaBio, ExcellGene, ExCellThera, Excelra, Exelixis, ExeVir Bio, Exicure, Exosome Sciences, Expansion Therapeutics, Experimental Drug Development Centre, Experimental Therapeutics Centre of Singapore, Expesicor, Exploit Technologies, ExpreS2ion Biotechnologies, Expressive Neuroscience, Exscientia, Eyam Vaccines and Immunotherapeutics, F-Star Therapeutics, Facial Pain Research Foundation, Facio Therapies, Factor Bioscience, FairJourney Biologics, Fannin, FAR Biotech, Fate Therapeutics, FatiAbGen, Fauna Bio, Federal Ministry of Health (Germany), Federation Bio, Femtogenix, Ferring Pharmaceuticals, FibroBiologics, Fibrogen, FibroGenesis, FightMND, Filament Health, Finch Therapeutics, FineImmune Biotechnology, Five Prime Therapeutics, Flagship Biosciences, Flagship Pioneering, Flamingo Therapeutics, Flare Therapeutics, Flatiron Health, Florabio, Florica Therapeutics, Florida Atlantic University Research, Florida International University, Flow Eighteen38, Flow Pharma, Fluidigm, Foghorn Therapeutics, Fondazione Telethon, Food and Drug Administration (FDA), Forcefield Therapeutics, Forendo Pharma, Forge Therapeutics, Forty Seven, Fosun Kite Biotechnology, Fosun Pharmaceutical, Foundation for Innovative New Diagnostics, Foundation Medicine, Foundery Innovations, Four Points Innovation, FOXO BioScience, Frame Cancer Therapeutics, Frametact, Fraunhofer Institute for Molecular Ecology (IME), Frederick National Laboratory For Cancer Research, Freeline Therapeutics, FreeMind Group, French National Institute for Agricultural Research, Friends of FSH Research, Frontier Medicines, FSD Pharma, Fujifilm, FUJIFILM Cellular Dynamics, Fujifilm Diosynth Biotechnologies, Fujitsu Laboratories, Fulcrum Therapeutics, Fundacion Medina, Fundacion Progreso y Salud, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Fusion Pharmaceuticals, FutureGen Biopharm, Fuzionaire, G1 Therapeutics, Gadeta, Gaeta Therapeutics, Gain Therapeutics, Galapagos, Gallant Therapeutics, Gandeeva Therapeutics, Gatehouse Bio, GC Biopharma, GC Pharma, Gedeon Richter, GE Healthcare, Geisinger Health System, Gemini Therapeutics, GEMoaB, GEn1E Lifesciences, Genagon Therapeutics, GeneCentric Therapeutics, Genechem, GeneCode, Genective, GeneData, GenEdit, Geneious Biologics, Genentech, Geneos Therapeutics, GeneQuantum Healthcare, Generate Biomedicines, Generation Bio, Generation Biotech, Generex Biotechnology, Generian Pharmaceuticals, Genesis Therapeutics, Genethon, Genetic Leap, Genevant Sciences, GenFleet Therapeutics, Genialis, Genisphere, GenKOre, Genmab, Gennao Bio, Genocea Biosciences, Genome and Company, Genome Biologics, Genome Insight, Genome Institute of Singapore, Genomenon, Genomic Biopharma, Genomics England, Genosco, Genovis, Genprex, Gensaic, GenScript Biotech, GenScript ProBio, GentiBio, Genuity Science, Genzyme, George Mason University, Georgetown University, George Washington University, GeoVax, German Cancer Research Center, German Federal Ministry of Education and Research, Gero, Gicell, Gigagen, GigaMune, GI Innovation, Gilead Sciences, Gilgamesh Pharmaceuticals, Ginkgo BioWorks, Gladstone Institutes, Glenmark Pharmaceuticals, Global Antibiotic Research and Development Partnership, GlobalBio, Global Blood Therapeutics, Global Cancer Technology, Global Virus Network, GlycoMantra, GlycoNet, Glycostem Therapeutics, Glycotope Biotechnology, GlycoT Therapeutics, Glykos, GNA Biosolutions, Gnosis Bioresearch, GNS Healthcare, Goethe University Frankfurt, Golden Meditech, Goldfinch Bio, Google, Gossamer Bio, GO Therapeutics, Government of Hong Kong, Government of Ireland, Government of South Korea, Gracell Biotechnologies, Graviton Bioscience, Gray Matter, Greenlight Biosciences, Grid Therapeutics, Griffith University, Grifols, Gritstone Bio, Grunenthal, GSK, GT Apeiron Therapeutics, GT Biopharma, Guangzhou Fanen Biotechnology, Guardant Health, Gubra, Gyroscope Therapeutics, H3 Biomedicine, Hackensack Meridian Health, Hadassah Medical Center, Haihe Laboratory of Cell Ecosystem, Hainan Sinotau Pharmaceutical, Halberd, HaloVax, Halozyme Therapeutics, HanAll Biopharma, HanAll Pharmaceuticals, HanchorBio, Hanmi Pharmaceutical, Hannover Medical School, Hansa Biopharma, Harbour Biomed, Harvard Medical School, Harvard University, HCW Biologics, HDT Bio, Health Holland, Healx, Heartseed, Heat Biologics, HebeCell, Hebrew University of Jerusalem, Heidelberg Pharma, Helmholtz Zentrum Munchen, Helomics, Helsinn Healthcare, HemoShear, Henlius Biotech, Henry M. Jackson Foundation, HepaTx, Heqet Therapeutics, Hereditary Neuropathy Foundation, Herophilus, HiFiBio, Highlight Therapeutics, HighRes Biosolutions, Hillstream BioPharma, Histogen, Hitachi, HitGen, Hoag Memorial Hospital Presbyterian, Hong Kong Baptist University, Hong Kong University of Science & Technology, Honor Epic Enterprises, Hopstem Biotechnology, Horizon Discovery, Horizon Europe, Horizon Pharma plc, Horizon Therapeutics, Hospital for Sick Children, Hoth Therapeutics, HotSpot Therapeutics, Hox Therapeutics, Hsiri Therapeutics, Hubrecht Institute, Hubrecht Organoid Technology, Hudson Institute of Medical Research, Humanigen, Hummingbird Bioscience, Hunterian Medicine, Huyabio International, Hybridize Therapeutics, I-mab, IAMA Therapeutics, IASO Biotherapeutics, Iaso Therapeutics, iBio, Icagen, Icahn School of Medicine at Mount Sinai, iCarbonX, Ichnos Sciences, Ichor Medical Systems, Iconic Therapeutics, Icosagen Group, Icosavax, IDBiologics, IDBS, IDEAYA Biosciences, iECURE, IFM Therapeutics, iGenomix, IGM Biosciences, IIT-Istituto Italiano di Tecnologia, Ikanik Farms, Ikena Oncology, Iksuda Therapeutics, Iktos, Ildong Pharmaceutical, ILiAD Biotechnologies, Illumina, ImaginAb, Imagine Pharmaceuticals, Imbrium Therapeutics, ImCheck Therapeutics, Imec, IMIDomics, Immagene, Immatics Biotechnologies, ImmBio, Immetas Therapeutics, Immix Biopharma, Immorna, ImmPACT Bio, Immunaccel, Immunai, ImmuneCyte Life Sciences, Immuneering, Immunic, Immunitas Therapeutics, ImmunityBio, ImmunoBiochem, ImmunoChina Pharmaceuticals, Immunocore, ImmunoForge, ImmunoGen, Immunome, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoQure, ImmunoScape, ImmunOs Therapeutics, Immunscape, ImmunXperts, ImmuPharma, Immuron, Immusoft, Immutep, IMPACT Therapeutics, Imperial College London, Impetis Biosciences, Imugene, IMV, Imvaq Therapeutics, In4Derm, INBRAIN Neuroelectronics, Inceptor Bio, Incyte, InDex Pharmaceuticals, Indiana University, Indivumed, Infection Innovation Consortium, Infectious Disease Research Institute (IDRI), Infex Therapeutics, Infinimmune, Infinity Pharmaceuticals, InflamaCORE, Inflammasome Therapeutics, Inhibrx, Initium Therapeutics, INmune Bio, Innate Pharma, InnDura Therapeutics, INNERVIA Bioelectronics, InnoCentive, InnoRNA, Innosuisse, Innovate UK, Innovent Biologics, Inotrem, Inovio, Inovio Pharmaceuticals, Inozyme Pharma, InProTher, Inserm, Inserm Transfert, Insilico Biotechnology, Insilico Medicine, Insitro, Instem, Institute for Basic Science, Institute for Research in Biomedicine, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for Systems Biology, Institute of Cancer Research, Institute of Materia Medica, Institute of Molecular and Clinical Ophthalmology Basel, Institute of Neurodegenerative Diseases, Institut Gustave Roussy, Institut Imagine, Institut Pasteur, Intas Pharmaceuticals, Integral Molecular, Integrated Biosciences, Integrated BioTherapeutics, Integra Therapeutics, Intel, IntelGenx, Intellia Therapeutics, Intellikine, INTELLiSTEM, Intermountain Healthcare, International Center for Genetic Engineering and Biotechnology, InterVenn, Intima Bioscience, IntoCell, Intravacc, Intrexon, iNtRON Biotechnology, Invasight, InveniAI, Invenra, Inventum Genetics, Invetx, InvisiShield Technologies, Invitae, InxMed, iOncologi, iOnctura, Ionis Pharmaceuticals, IONTAS, Iota Biosciences, Iovance Biotherapeutics, iPrime Therapeutics, iProgen Biotech, Ipsen, IRBM, Isomorphic Labs, IsoPlexis, Israeli National Authority for Technological Innovation, Israel Institute for Biological Research, ITM Isotopen Technologien, Itochu, iTolerance, Iveric Bio, Ix Therapeutics, J2H Biotech, Jacobio Pharmaceuticals, Jaguar Health, James Cook University, James Hutton Institute, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janux Therapeutics, Japan Agency for Medical Research and Development, Javelin Biotech, Jazz Pharmaceuticals, JCR Pharmaceuticals, Jesse's Journey, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu Hengrui Pharmaceuticals, Jiangsu NHWA Pharmaceutical, Jnana Therapeutics, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, JSR, JSR Life Sciences, Jubilant Biosys, Jubilant Therapeutics, Junshi Biosciences, Jura Bio, Juvenile Diabetes Research Foundation, JW Therapeutics, Kadimastem, Kadmon Pharmaceuticals, Kainos Medicines, Kaken Pharmaceutical, Kaleido Biosciences, KaliVir Immunotherapeutics, Kallyope, KangaBio, Kansas State University, Kantonsspital St. Gallen, Kanyr Pharma, Karolinska Institute, Karuna Therapeutics, KBio, KBP BioSciences, KeifeRx, Keio Gijuku University, Kelonia Therapeutics, KELTIC Pharma, Kelun-Biotech Biopharmaceutical, Kennedy Institute of Rheumatology, kENUP Foundation, Kermode Biotechnologies, Keygene, Kimer Med, Kings College London, KinoPharma, Kiromic Biopharma, Kite Pharma, Kiyatec, Kleo Pharmaceuticals, Knopp Biosciences, Kobe University, Kodiak Sciences, Korea Institute of Nuclear Medicine, Korro Bio, Kriya Therapeutics, Kronos Bio, KSQ Therapeutics, KTH Royal Institute of Technology, Kumquat Biosciences, Kures, Kurma Life Sciences Partners, Kvantify, Kymera Therapeutics, Kyn Therapeutics, Kyowa Hakko Kirin, Kyowa Hakko Kirin Pharmaceuticals, Kytopen, Kyttaro, Kyushu University, Kyverna Therapeutics, LabGenius, Laboratory Corporation of America, Lacerta Therapeutics, La Jolla Institute for Allergy & Immunology, Landmark Bio, Lantern Pharma, Lantheus Holding, Lassen Therapeutics, Latham BioPharm Group, Lava Therapeutics, Laxai Pharma, Lead Pharma, Lee Moffitt Cancer Center, Legend Biotech, LegoChem Biosciences, Leiden University, Leidos, Lenovo, LEO Pharma, Lesaffre, Les Laboratoires Servier, Leucid Bio, LeukoCom, Leveragen, LEXEO Therapeutics, LG Life Sciences, LianBio, Libera Bio, LiberoThera, Lieber Institute, LifeArc, Life Edit Therapeutics, LifeMap Sciences, LifeMine Therapeutics, LIfT BioSciences, Ligand Pharmaceuticals, Light Chain Bioscience, Liminal BioSciences, LimmaTech Biologics, Lineage Cell Therapeutics, LinkBio, LinKinVax, Linus Biotechnology, Lion TCR, Lipidomics Consulting, Lipigon Pharmaceuticals, LiteVax, Lixte Biotechnology, LMU University Hospital Munich, LNC, Locus Biosciences, LogicBio Therapeutics, Logomix, Long Island University, Longwood University, Lonza, LoQus23 Therapeutics, Loulou Foundation, Loxo Oncology, LUCA Science, Lucidam, Lucid Psycheceuticals, Lucy Therapeutics, Lumen Biomedical, Luminary Therapeutics, LUNAC Therapeutics, Lunaphore, Lundbeck, Lundquist Institute, Lund University, Lung Cancer Research Foundation, Lupus Research Alliance, Luxna Biotech, Lycia Therapeutics, Lyell Immunopharma, LyGenesis, Lynk Pharmaceuticals, Lysando, Lysogene, Lytica Therapeutics, M2Gen, Mablink Bioscience, MAbSilico, Mabwell Bioscience, Mabylon, Machavert Pharmaceuticals, Macomics, Macrogenics, Macromoltek, Magdalena Biosciences, Magenta Therapeutics, Magle Chemoswed, Magnetrap, Mainz University Medical Centre, MAKScientific, Mammoth Biosciences, Manhattan BioSolutions, Mannin Research, MapLight Therapeutics, Marengo Therapeutics, Marinus Pharmaceuticals, Mark Foundation for Cancer Research, Maruho, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mass General Brigham, Massive Bio, Mateon Therapeutics, Matica Biotechnology, Matinas Biopharma, Max-Planck, Max Biopharma, Maxcyte, Maxion Therapeutics, Mayo Clinic, Maze Therapeutics, McGill University, McQuade Center for Strategic Research and Development, mCureX Therapeutics, MD Anderson Cancer Center, MDimune, Medgenics, Mediar Therapeutics, Medicago, Medical College of Wisconsin, Medical Research Futures Fund, Medical University of Graz, Medical University of Vienna, Medical University South Carolina, Medicinal Genomics, Medicines Discovery Catapult, MediciNova, MEDiC Life Sciences, Medicure, Medi Futures, MediGene, Medigen Vaccine Biologics, MediLink Therapeutics, Medimabs, MedImmune, Medipal Holdings, MediSix Therapeutics, Medison Pharma, Medivir, MedPacto, Medtronic, Meharry Medical College, Meiji Seika, MeiraGTx, Mekonos, Mellow Hope Bio Chem, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Menarini, MercachemSyncom, Merck and Co, Merck Animal Health, Merck KGaA, Merck Sharpe & Dohme, Merdury Biopharmaceutical, Mersana Therapeutics, Merus, Mestag Therapeutics, Metabolon, Metagenomi, Metis Therapeutics, Metrion Biosciences, MGFB, Michael J Fox Foundation, Microbiotix, MicroMGx, Microsoft, Mie University, MIGAL Galilee Research Institute, MILA International, MilliporeSigma, MiMedx, Mimetas, MiNA Therapeutics, MindRank AI, Minerva Biotechnologies, MiNK Therapeutics, Minovia Therapeutics, Miralogx, miRecule, Mirimus, Mirus Bio, Mission Cure, Mission Therapeutics, Mitacs, Mitobridge, MitoCanada Foundation, Mitochondrial Innovation Initiative, MitoSense, Mitsubishi Tanabe Pharma, MOBILion Systems, Modag, Modalis Therapeutics, Moderna, ModeX Therapeutics, Modifi Bio, Modulus Discovery, Molcure, Molecular Assemblies, Molecular Health, Molecular Partners, Molecular Templates, Molecure, MOMA Therapeutics, Monash University, Monte Rosa Therapeutics, Morningside Ventures, Morphic Therapeutic, MorphoSys, Mor Research Applications, Mosaic Biosciences, Mosaic ImmunoEngineering, Moss Genomics, Mount Sinai Health System, MRM Health, MSD, Multimmune, Murdoch Childrens Research Institute, Mustang Bio, MyBiotics Pharma, My Care Express Merrillville, Mydecine Group, Myeloid Therapeutics, Mymetics, MYND Life Sciences, myNEO, MyoKardia, My Personal Therapeutics, Myricx Bio, Myrtelle, Mythic Therapeutics, Mytide Therapeutics, myTomorrows, n-Lorem Foundation, Nagoya University Graduate School of Medicine, Namocell, Nanite, Nanjing Leads Biolabs, Nanna Therapeutics, NanoCellect Biomedica, Nanoform, NanoMab Technology, NanoString Technologies, NantKwest, NantOmics, NapaJen Pharma, Nashville Biosciences, Natera, National Cancer Center of Japan, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Centre for Research and Development, National Comprehensive Cancer Network (NCCN), National Eye Institute, National Health Service, National Heart, Lung and Blood Institute, National Human Genome Research Institute, National Institute for Bioprocessing Research and Training, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Infectious Diseases, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Standards and Technology, National Institute on Aging, National Institutes of Biomedical Innovation, Health and Nutrition, National Institutes of Health, National Research and Innovation Agency of Uruguay, National Research Council Canada, National Research Council of Canada, National Science Foundation, National University of Ireland, Galway (NUI Galway), National University of Singapore, Nature Technology, Nautilus Biotech, Navigo Proteins, Navrogen, NBE Therapeutics, Ncardia, Nebula Genomics, NEC, Nektar Therapeutics, Neochromosome, NeoCura Bio-Medical Technology, Neogap Therapeutics, Neo Gene Pharm, Neogene Therapeutics, Neogenomics, NeoImmuneTech, Neomorph, NeoPhore, NeoX Biotech, Nerviano Medical Sciences, Nested Therapeutics, Netherlands Cancer Institute, NetraMark, NETRIS Pharma, NeuBase Therapeutics, NeuCyte, Neukio Biotherapeutics, Neumora Therapeutics, Neurimmune Therapeutics, Neuro3 Therapeutics, Neurocrine Biosciences, Neurodon, Neurogene, NeuroLucent, Neurophth Therapeutics, Neuropore Therapies, NeuroTracker, NeuroTrauma, Neuvogen, NewBiologix, Newomics, Neximmune, NextVivo, NGM Biopharmaceuticals, Nilogen Oncosystems, Nimble Therapeutics, Nimbus Therapeutics, NIMIUM Therapeutics, NIMML Institute, NImmune Biopharma, Nippon Shinyaku, Nirogy Therapeutics, Nitrome Biosciences, NJ Bio, Nkarta Therapeutics, NMI Natural and Medical Sciences Institute, Noachis Terra, Noga Therapeutics, Noile-Immune Biotech, Nona Biosciences, NonExomics, Nordic Nanovector, Normunity, North Carolina State University, North Med, Northwestern University, Nostrum Biodiscovery, Notch Therapeutics, Novartis, Novavax, Novellus Biopharma, Novellus Therapeutics, Novocure, Novogene, Novoheart, Novome Biotechnologies, Novo Nordisk, Novoron Bioscience, Noxopharm, Nrgene, NRG Therapeutics, Nucleai, NuclixBio, NuGenerex Immuno-Oncology, Numab, Numerate, Nuntius Therapeutics, Nurix Therapeutics, Nurosene, Nuvisan Pharma Services, Nvidia, NWO.ai, NXT Biomedical, Nykode Therapeutics, NysnoBio, NYU Langone Medical Center, Oblique Therapeutics, Obsidian Therapeutics, Ocean Biomedical, Octagon Research Solutions, Ocular Therapeutix, Ocumension Therapeutics, Ohio State University, Oklahoma Medical Research Foundation, Olema Oncology, OliPass, Olivia Newton-John Cancer Research Institute, OliX Pharmaceuticals, Omega Therapeutics, OmniAb, OmniaBio, Omniose, OmniSpirant, Ona Therapeutics, OncoArendi Therapeutics, Oncocross, Oncode Institute, Oncodesign, OncoDNA, Oncogenuity, Oncoheroes Biosciences, OncoHost, OncoImmunity, Oncologie, Oncology Pharma, Oncology Research Information Exchange Network, OncoMyx Therapeutics, OncoNano Medicine, Oncora Medical, Oncorus, OncoStatyx, Oncovir, Oncovita, Oncozen, Oncternal Therapeutics, One Drop, OneThree Biotech, ONI, oNKo-innate, ONK Therapeutics, Ono Pharmaceutical, Ontario Institute for Cancer Research, Ontochem, Onward Therapeutics, Opal Therapeutics, OpenAI, OpenBench, Ophthotech, OPKO Health, Opsis Therapeutics, Optieum Biotechnologies, Oragenics, Orange Grove Bio, Orano Med, Orbit Discovery, Orca Bio, Orchard Therapeutics, Ordaos Bio, Orebro University, Oregon Health Sciences University, Orexia Therapeutics, Organo Therapeutics, Organovo, Orgenesis, Origenis, OrigiMed, Orion, Orion Genomics, Orionis Biosciences, Orna Therapeutics, OrsoBio, Orum Therapeutics, Oryzon, Oscotec, OSE Immunotherapeutics, Oslo University Hospital, Ossium Health, Ostentus Therapeutics, Otsuka, Outpace Bio, Overland Pharmaceuticals, Ovid Therapeutics, Owkin, Oxford Biodynamics, Oxford BioMedica, Oxford BioTherapeutics, Oxford Drug Design, Oxford Nanopore Technologies, Oxgene, Oyster Point Pharma, Pacific Biosciences, PACT Pharma, Palantir, panCELLa, Pandion Therapeutics, Pangu BioPharma, Pantherna Therapeutics, Papyrus Therapeutics, PAQ Therapeutics, Paragon Therapeutics, Paraza Pharma, Parexel, Parkinson's Disease Foundation, Parkinson's UK, Parthenon Therapeutics, Parvus Therapeutics, Pascal Biosciences, Pasithea Therapeutics, Passage Bio, PathAI, Path BioAnalytics, Pathios Therapeutics, PatientsLikeMe, Pearl Bio, Peking Union Medical College, Penn State Cancer Institute, Pennsylvania Biotechnology Center, PentixaPharm, Pepscan, PeptiDream, Peptilogics, Perelman School of Medicine, Persephone Biosciences, Personal Genome Diagnostics, Personalis, PetaGene, Peter Doherty Institute for Infection and Immunity, Peter MacCallum Cancer Institute, Pfenex, Pfizer, PGI Drug Discovery, Phanes Therapeutics, PharmAbcine, PharmaEssentia, PharmaJet, PharmaTher, Pharming Group, Pharmsynthez, PhaseBio Pharmaceuticals, Phase Genomics, PHAXIAM Therapeutics, Phenomic AI, PhenoVista Biosciences, Pheon Therapeutics, Pherecydes Pharma, Philogen, Phio Pharmaceuticals, Phlox Therapeutics, Phoenix PharmaLabs, PhoreMost, PhotonPharma, pH Pharma, PhysIQ, PicnicHealth, Pieris Pharmaceuticals, Pierre Fabre, PineTree Therapeutics, Pionyr Immunotherapeutics, Plantae Biosciences, Pleco Therapeutics, Plexium, Plex Research, Pliant Therapeutics, Pluristem Therapeutics, Pluristyx, POINT Biopharma, PolarisQB, Polyphor, Portal Bioscience, Poseida Therapeutics, PostEra, PPD, Pragma Bio, Prapela, Praxis Precision Medicines, Precision BioSciences, PrecisionLife, Precision NanoSystems, Precision Virologics, Predictive Oncology, Prellis Biologics, Prelude Therapeutics, Premas Biotech, Presage Biosciences, Prevail Therapeutics, Prevencio, Prime Medicine, Primordial Genetics, Princeton University, PRISM BioLab, ProBioGen, Procarta Biosystems, ProfoundBio, ProFound Therapeutics, Prokaryotics, ProMab Biotechnologies, Promega, Prometheus Biosciences, ProQinase, ProQR Therapeutics, Proteic Bioscience, ProteinQure, ProteinTech, Protelica, Proteona, Proteovant Therapeutics, Proteros biostructures, ProThera, Providence Therapeutics, PROVIREX Genome Editing Therapies, Proxygen, PsyBio Therapeutics, PsychoGenics, PTC Therapeutics, Pulmatrix, Pulmonary Fibrosis Foundation (PFF), Purdue Pharma, Purdue University, Pure Biologics, Purespring Therapeutics, PureTech Health, Purnovate, Purple Biotech, Q-State Biosciences, QDX, Qiagen, Qilu Pharmaceutical, Qpex Biopharma, Quadira Biosciences, Qualigen, Quanterix, Quantoom Biosciences, Quebec Consortium for Drug Discovery, Queen Mary University of London, Queensland Institute of Medical Research (QIMR), Queensland University of Technology, Queens University Belfast, Quell Therapeutics, Quercis Pharma, Quoin Pharmaceuticals, QureTech Bio, R4D Biotech, rAAVen Therapeutics, Radboud University Nijmegen, Radiance Biopharma, Radionetics Oncology, Rady Children's Institute for Genomic Medicine, Ragon Institute, Rain Oncology, Rakovina Therapeutics, Rakuten Medical, Rallybio, Ramot at Tel Aviv University, Ranok Therapeutics, Rarebase, Rational Vaccines, RayzeBio, Realm IDx, ReAlta Life Sciences, Rebus Biosystems, Recce Pharmaceuticals, Recida Therapeutics, ReCode Therapeutics, Recombia Biosciences, Recombinetics, Recursion, Redbiotec, Redwire, Redx Pharma, RefleXion Medical, Refuge Biotechnologies, Regen BioPharma, Regencell Bioscience, Regeneron Pharmaceuticals, RegenLab, Regenxbio, Regional Cancer Institute of Montpellier, Reglagene, Regor Therapeutics, ReiThera, Relief Therapeutics, REMD Biotherapeutics, Remix Therapeutics, Renato Dulbecco Foundation, RenBio, Renovacare, Renovacor, Renown Institute for Health Innovation, Repare Therapeutics, Repertoire Genesis, Repertoire Immune Medicines, Replay, Replicate Bioscience, Replicel Life Sciences, ReproCell, Repurpose.AI, Research Council of Norway, Res Nova Bio, Resonant Therapeutics, RespireRx Pharmaceuticals, RetinAI Medical, Retrogenix, Retrophin, Revelation Biosciences, Reverie Labs, ReviR Therapeutics, Revitope Oncology, ReviveMed, Revive Therapeutics, RevolKa, Revolution Medicines, Revvity, Reyon Pharmaceuticals, Rgenta Therapeutics, Rheos Medicines, Ribometrix, Rice University, Rigel Pharmaceuticals, Rigshospitalet, RIKEN Research Institute, RIKEN Yokohama Institute Omics Science Center, RION, RNAGene, Roche, Rockefeller University, RogCon Biosciences, Roivant Sciences, Rona Therapeutics, RoosterBio, Rosa, Rosalind, Rosalind Franklin University of Medical Sciences, Rosetta Biosciences, RosVivo Therapeutics, Roswell Biotechnologies, Roswell Park Cancer Institute, Royal Children’s Hospital, RQ Biotechnology, Rubedo Life Sciences, RubrYc Therapeutics, Rutgers University, RxCell, Ryvu Therapeutics, Rznomics, SAB Biotherapeutics, Saccharo, Saint-Gobain Life Sciences, SalioGen Therapeutics, Salipro Biotech, Salk Institute, Sana Biotechnology, SanBio, SanegeneBio, Sanford Burnham Institute, Sangamo Therapeutics, Saniona, Sanofi, Sanofi-Pasteur, Santa Cruz Biotechnology, Santen Pharmaceutical, Santhera Pharmaceuticals, Sanyou Biopharmaceuticals, Saphetor, Sapphire Biotech, Sarcomatrix Therapeutics, Sarepta Therapeutics, Satellos Bioscience, SaudiVax, Scailyte, Scenic Biotech, Schepens Eye Research Institute, Scholar Rock, Schrodinger, Science for Life Laboratory, SciNeuro Pharmaceuticals, Scipher Medicine, SciSparc, Sciwind Biosciences, SCM Pharma, Scorpion Therapeutics, Scottish Enterprise, Screen Therapeutics, Scribe Therapeutics, Scripps Research Institute, Scriptr Global, Seagen, Seattle Children's Hospital, Seattle Children's Therapeutics, Seattle Childrens Research Institute, Seattle Genetics, Secarna Pharmaceuticals, Second Genome, Sedec Therapeutics, Seed Therapeutics, Seismic Bio, Seismic Therapeutic, Selagine, Selecta Biosciences, Selecxine, Selexis, Selonterra, Selvita, SemaThera, Seneca Therapeutics, Sengenics, SEngine Precision Medicine, Sentia Medical Sciences, Senti Biosciences, Seoul National University, Septerna, Seqirus, Sequence Bio, SeraNovo, Seraxis, Seres Therapeutics, Sernova, Serotiny, Serum Institute of India, Seven Bridges Genomics, Shanghai Affinity Biopharmaceutical, Shanghai Cell Therapy Group, Shanghai Miracogen, Shanghai Pharmaceutical, Shanghai ZhenGe Biotechnology, ShangPharma, Shape Therapeutics, Shasqi, Shattuck Labs, Sheba Medical Center, Shepherd Therapeutics, Sherlock Biosciences, Shimadzu, Shinshu University, Shionogi, Shionogi Pharma, Shoreline Biosciences, Sibylla Biotech, Sigilon Therapeutics, Signet Therapeutics, SilcsBio, Silence Therapeutics, Simcere Pharmaceuticals, Simnova, Simulations Plus, Singapore Eye Research Institute (SERI), Singapore Sengkang General Hospital, Singlera Genomics, Singleron Biotechnologies, Singular Genomics Systems, Singzyme, Sino Biological, SinoMab Bioscience, Sinorda Biomedicine, Sirion Biotech, Sirnaomics, Sirona Biochem, Sironax, SiSaf, Siteman Cancer Center, SiteOne Therapeutics, Sitryx, SK Biopharmaceuticals, SK Bioscience, SK Chemicals, Skip Therapeutics, Skyhawk Therapeutics, Skyline Therapeutics, Skysong Innovations, Smart Immune, SmartPharm Therapeutics, Solarvest BioEnergy, Solasia Pharma, Soleno Therapeutics, Solentim, Solid Biosciences, Soligenix, Solve Therapeutics, SomaLogic, Sonoma BioTherapeutics, Sony, Soonchunhyang University Hospital Bucheon, SOPHiA Genetics, Sorrento Therapeutics, Sosei, Sosei Heptares, SOTIO, Spanios, Spanish National Cancer Research Centre, SparingVision, Spark Therapeutics, Specifica, SpeeDx, Spindle Biotech, SpliceBio, Spring Bank Pharmaceuticals, SpringWorks Therapeutics, Sprint Biosciences, SpyBiotech, SQZ Biotech, SRI International, St. Baldrick's Foundation, St. Jude Children's Research Hospital, Stallargenes, Stallergenes Greer, Standigm, Stand Up To Cancer, Stanford University, Stanford University School of Medicine, Starpharma, STC Biologics, Stem Genomics, Stemline Therapeutics, StemoniX, Stem Pharm, StemSight, Step Pharma, SteroTherapeutics, Stoke Therapeutics, Storm Therapeutics, Strand Therapeutics, STRATIFYER Molecular Pathology, StrideBio, Structural Genomics Consortium, Strykagen, Sud Investments, Sumaya Biotech, Sumitomo Dainippon Pharma, Sumitomo Mitsui Banking Corporation, Sumitovant Biopharma, Sunnybrook Research Institute, Sun Pharma Advanced Research Company, SunRock Biopharma, Sunshine Biopharma, Sun Yat-sen University, Supercell Biotechnology, Surface Oncology, Sutro Biopharma, Suzhou Porton Advanced Solutions, Suzhou Ribo Life Sciences, SwanBio Therapeutics, Swedish Research Council, Syapse, Sybleu, Syena, Sygnature Discovery, Symbasis, Symphogen, Symvivo, Synaffix, Synbal, Synbiotic Health, Syncromune, Synedgen, SynerK, Syngenta, Synlogic, Syntekabio, Synthego, Synthekine, SyntheX, Syracuse Biopharma, Syros Pharmaceuticals, Systems Oncology, T-Cure Bioscience, Tachyon Therapeutics, Taiho, Taisho Pharmaceutical, Takara Bio, Takeda Oncology, Takeda Pharmaceutical, Takeda Ventures, Talem Therapeutics, Tallac Therapeutics, Talus Bioscience, TamRx, Tanabe Research Laboratories, Tantu Therapeutics, TARA Biosystems, Targovax, Taros Chemicals, Tarus Therapeutics, Tavotek Biotherapeutics, Tavros Therapeutics, Taysha Gene Therapies, TB Alliance, TC BioPharm, TCR2 Therapeutics, Tegmine Therapeutics, Teijin, Tella, Telomir Pharmaceuticals, Temple University, Tempus, Ten63 Therapeutics, TeneoBio, TenNor Therapeutics, Tentarix Biotherapeutics, Terran Biosciences, Terray Therapeutics, Terumo Blood and Cell Technologies, Tesis Biosciences, Tessa Therapeutics, Tessera Therapeutics, Tetra Bio-Pharma, Tetragenetics, Tetra Pharm Technologies, Teva Pharmaceutical Industries, Tevard Biosciences, Texas A&M Health Science Center, Texas A&M University, Texas Heart Institute, TFC Therapeutics, TG Therapeutics, The International AIDS Vaccine Initiative, The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center, Themis Bioscience, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Theragen, TheraPanacea, Therapeutic Solutions International, Thermo Fisher Scientific, Theseus Pharmaceuticals, The Silverstein Foundation for Parkinson's, The Technical University Of Munich, ThinkCyte, ThinkingNodeLife, Thoeris, Thorne HealthTech, Thought Leadership & Innovation Foundation, Thylacine Biotherapeutics, Tianjin CanSino Biotechnology, Tianjin University, Tiba Biotech, Titan Pharmaceuticals, TiumBio, T Med, Tmunity Therapeutics, Tokyo Medical and Dental University, Tolo Biotech, TONIX Pharmaceuticals, Toolgen, Toronto Centre for Psychedelic Science, Toronto Innovation Acceleration Partners, Totient, Totus Medicines, Touchlight, Trakcel, TransCelerate BioPharma, TransCode Therapeutics, Transgene, Translate Bio, Translational Genomics Research Institute, TransThera, Traverse Biosciences, Treadwell Therapeutics, TreeFrog Therapeutics, Treventis, TRexBio, Trianni, Trinity College Dublin, Trinomab Biotech, Triumvira Immunologics, TRT Innovations, TrueBinding, Trutino Biosciences, TScan Therapeutics, Tubulis, Tufts University, TuHURA Biopharma, TuHURA Biosciences, TumorGen, TumorGenesis, Turbine, Turn Biotechnologies, Turnstone Biologics, Turn Therapeutics, Twinstrand Therapeutics, Twist Bioscience, twoXAR, Tyris Therapeutics, Ubiquigent, Ubix Therapeutics, UCB, UCL Business, Ultivue, Ultragenyx Pharmaceuticals, Umoja Biopharma, Uni-Bio Science, UniQuest, UniQure, Unison Medicines, United Immunity, Univercells, Univeristy of Durham, Universal Cells, Universite Laval, University College London, University Gottingen, University Health Network, University Hospital Heidelberg, University Hospital Jena, University Libre of Brussels, University Medical Center Groningen, University of Aberdeen, University of Alabama at Birmingham, University of Amsterdam, University of Arizona, University of Barcelona, University of Basel, University of Bath, University of Bonn, University of British Columbia, University of Calgary, University of California, Davis, University of California, San Diego, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of California Santa Barbara, University of Central Florida Research Foundation, University of Chicago, University of Cincinnati, University of Colorado, University of Connecticut, University of Copenhagen, University of Dundee, University of Edinburgh, University of Florida, University of Florida Research Foundation, University of Geneva, University of Georgia, University of Glasgow, University of Hawaii, University of Helsinki, University of Hong Kong, University of Houston, University of Illinois at Chicago, University of Iowa, University of Kiel, University of Lausanne, University of Lethbridge, University of Louisville, University of L’Aquila, University of Manchester, University of Marburg, University of Maryland, University of Maryland Baltimore, University of Maryland School of Medicine, University of Massachusetts, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Michigan, University of Minnesota, University of Missouri, University of Montreal, University of Nebraska, University of New South Wales, University of North Carolina, University of Oklahoma, University of Oslo, University of Oxford, University of Pennsylvania, University of Pennsylvania School of Veterinary Medicine, University of Pittsburgh, University of Queensland, University of Saskatchewan, University of Sheffield, University of South Australia, University of Southern California, University of Sydney, University of Technology Sydney, University of Texas, University of Texas Health SCience Center at San Antonio, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of the Witwatersrand, University of Tokyo, University of Toronto, University of Tsukuba, University of Tubingen, University of Vermont, University of Verona, University of Virginia, University of Washington, University of Wisconsin, University of Wisconsin-Madison, University of Wollongong, University of Wurzburg, University of Zurich, Unravel Biosciences, Unum Therapeutics, Upadia, Uppsala University, Uppthera, UroGen Pharma, USANA Health Science, US Army Medical Research and Material Command, US Army Medical Research Institute of Chemical Defense, US Army Medical Research Institute of Infectious Diseases, US Government, Usynova Pharmaceuticals, Utrecht University, UWM Research Foundation, Vaccinex, Vaccitech, Valence Discovery, Valitacell, Vall d’Hebron Research Institute, Valo Health, Valo Therapeutics, Van Andel Institute, Vanda Pharmaceuticals, Vanderbilt University, VantAI, Variant Pharmaceuticals, Variational AI, Vaxalto Biotherapeutics, VaxEquity, Vaxil BioTherapeutics, Vaximm, VaxThera, Vaxxinity, VBI Vaccines, Vect-Horus, VectorY Therapeutics, Velabs Therapeutics, VenatoRx, Veneno Technologies, Venturis Therapeutics, Ventus Therapeutics, Veracyte, Verana Health, Veranome Biosystems, Verantos, Verastem, Veraxa Biotech, Verge Genomics, Verily, VerImmune, Verismo Therapeutics, Vernalis, Versatope Therapeutics, Verseau Therapeutics, Vertex Pharmaceuticals, Verve Therapeutics, Vetigenics, Vetophage, VIB, Vibliome Therapeutics, Victoria University, Viewpoint Molecular Targeting, Vifor Pharma, ViGeneron, ViiV Healthcare, Vincere Biosciences, Vinnova, Viome, Vipergen, Viravaxx, Vir Biotechnology, Virginia Commonwealth University, Virginia Polytechnic Institute and State University, Virion Therapeutics, Virogen, Vittoria Biotherapeutics, Vituity, Viva Biotech, Vividion Therapeutics, Vivlion, vivoPharm, Vivoryon Therapeutics, Vivtex, Volastra Therapeutics, Voltron Therapeutics, Vor Biopharma, Voronoi, Voyager Therapeutics, Vuja De Sciences, Vyant Bio, Vycellix, VYNE Therapeutics, Wageningen University, Wake Forest Institute for Regenerative Medicine, Wake Forest University, Walking Fish Therapeutics, Washington University in St Louis, WaVe Lifesciences, WAVE Life Sciences, Weatherden, Weizmann Institute, Wellcome Trust Sanger Institute, Wellmarker Bio, Western Digital, Westlake Pharma, Whitehead Institute, WhiteLab Genomics, Willow Biosciences, WindMIL Therapeutics, WinterLight Labs, Wisconsin Alumni Research Foundation, Wiseman Cancer Research Foundation, Wistar Institute, Wonkwang University, Wren Therapeutics, WUGEN, WuXi Biologics, WuXi XDC, Wyss Institute, X-chem, xCella Biosciences, Xcell Biosciences, Xcellomics, Xencor, Xenetic Biosciences, Xilio Therapeutics, Xilis, Ximbio, Xlife Sciences, Xoma, XtalPi, Xylyx Bio, Xyphos Biosciences, Y-Biologics, Y-Trap, Yale University, YASKAWA Electric, Yatiri Bio, Yeda Research and Development Company, Yissum Research Development, Yiviva, Ymir Genomics, Ymmunobio, Yufan Biotechnologies, Yuhan Corporation, YUMAB, Yumanity Therapeutics, ZabBio, ZAI Laboratory, Zealand Pharma, ZebiAI Therapeutics, ZeClinics, Zelluna Immunotherapy, Zentalis Pharmaceuticals, Zenyaku Kogyo, Zephyr AI, Zhejiang Doer Biotechnology, Ziopharm Oncology, Zoetis, Zogenix, ZS Pharma, Zydus Cadila, Zymeworks, ZYUS Life Sciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.